Iambic Therapeutics, Inc. (NASDAQ:IAM) IPO

Iambic Therapeutics, Inc.

IPO

Priced at US$16.00 a share on Oct 14, 2026.

Price
US$16.00 a share
Shares offered
9,375,000 shares of common stock
Offering size
US$150 million
Underwriters' option
Up to 1,406,250 more shares
Listing
IAM on the Nasdaq Global Select Market
Underwriters
J.P. Morgan, Jefferies, BofA Securities, Citigroup · In the order on the cover
Shares delivered
On or about Oct 16, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceJul 24, 2026
Filed publiclySep 21, 2026
Amended onceOct 8, 2026
Shares registered with an exchangeOct 13, 2026
Declared effective by the SECOct 14, 2026
Final prospectus, with the priceOct 15, 2026

From the cover of the final prospectus (424B4) filed Oct 15, 2026